Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder, affecting one in ten people aged over 65 years. Despite the severity of the disease, early diagnosis of AD is still challenging due to the low accuracy or high cost of neuropsychological tests and neuroimaging. Here we report...

Full description

Saved in:

Bibliographic Details
Published in:	Nature communications Vol. 11; no. 1; pp. 119 - 9
Main Authors:	Kim, Kayoung, Kim, Min-Ji, Kim, Da Won, Kim, Su Yeong, Park, Steve, Park, Chan Beum
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 08.01.2020 Nature Publishing Group Nature Portfolio
Subjects:	147/135 147/143 147/3 631/61/350/59 639/301/357/73 692/699/375/365/1283 82/1 9/10 Accuracy Alignment Alzheimer Disease - blood Alzheimer Disease - diagnosis Alzheimer's disease Amyloid beta-Peptides - blood Biomarkers Biomarkers - blood Biosensing Techniques - instrumentation Biosensing Techniques - methods Blood Blood plasma Coefficient of variation Diagnosis Humanities and Social Sciences Humans Low concentrations Medical imaging Middle Aged multidisciplinary Nanotechnology Nanotubes Nanotubes, Carbon - chemistry Neurodegenerative diseases Neuroimaging Plasma Science Science (multidisciplinary) Selectivity Sensitivity Sensor arrays Sensors Single wall carbon nanotubes Tau protein tau Proteins - blood
ISSN:	2041-1723, 2041-1723
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!